SI1546182T1 - Sestavki in postopki za diagnozo in zdravljenje tumorja - Google Patents

Sestavki in postopki za diagnozo in zdravljenje tumorja

Info

Publication number: SI1546182T1
Authority: SI; Slovenia
Prior art keywords: compositions; tumor; diagnosis; treatment; methods
Prior art date: 2002-09-11

Application number

SI200331964T

Other languages

English (en)

Inventor

David P Davis

Frederic J Desauvage

William I Wood

Zemin Zhang

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-11

Filing date

2003-09-05

Publication date

2011-04-29

2003-09-05 Application filed by Genentech Inc filed Critical Genentech Inc

2011-04-29 Publication of SI1546182T1 publication Critical patent/SI1546182T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Oncology (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)
Medicinal Preparation (AREA)

SI200331964T 2002-09-11 2003-09-05 Sestavki in postopki za diagnozo in zdravljenje tumorja SI1546182T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US41016602P	2002-09-11	2002-09-11
PCT/US2003/027886 WO2004024063A2 (en)	2002-09-11	2003-09-05	Compositions and methods for the diagnosis and treatment of tumor
EP03752035A EP1546182B1 (en)	2002-09-11	2003-09-05	Compositions and methods for the diagnosis and treatment of tumor

Publications (1)

Publication Number	Publication Date
SI1546182T1 true SI1546182T1 (sl)	2011-04-29

Family

ID=31994078

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200331964T SI1546182T1 (sl)	2002-09-11	2003-09-05	Sestavki in postopki za diagnozo in zdravljenje tumorja

Country Status (10)

Country	Link
US (3)	US20120045390A1 (sl)
EP (2)	EP1578760B1 (sl)
JP (4)	JP2005537810A (sl)
AT (1)	ATE494296T1 (sl)
AU (3)	AU2003270348B2 (sl)
CA (2)	CA2498000C (sl)
DE (1)	DE60335636D1 (sl)
ES (2)	ES2359055T3 (sl)
SI (1)	SI1546182T1 (sl)
WO (2)	WO2004024064A2 (sl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120045390A1 (en) *	2002-09-11	2012-02-23	Genentech, Inc.	Composition and Methods for the Diagnosis and Treatment of Tumor
WO2006034300A2 (en) *	2004-09-17	2006-03-30	Cornell Research Foundation, Inc.	Great wall kinases and uses thereof
MX2007006252A (es)	2004-11-24	2009-02-13	Theraptosis Sa	Nuevos peptidos utiles como inhibidores duales de caspasa-2/-6 y sus aplicaciones biologicas.
CA2589918A1 (en) *	2004-12-08	2006-06-15	Dorre Grueneberg	Method for measuring resistance or sensitivity to docetaxel comprising detection of tacc3
JP2008154573A (ja) *	2006-03-31	2008-07-10	Toyobo Co Ltd	可溶性グルコースデヒドロゲナーゼ（ｇｄｈ）を含む組成物の安定性を向上する方法
US20100119529A1 (en) *	2006-05-12	2010-05-13	Furgeson Darin Y	Elastin-like polymer delivery vehicles
HUE037173T2 (hu)	2006-08-08	2018-08-28	Univ Bonn Rheinische Friedrich Wilhelms	5'-Foszfát-oligonukleotidok szerkezete és alkalmazása
US20090011060A1 (en) *	2007-07-06	2009-01-08	Peter Koepke	Campsiandra angustifolia extract and methods of extracting and using such extract
US7879369B2 (en)	2007-09-18	2011-02-01	Selvamedica, Llc	Combretum laurifolium Mart. extract and methods of extracting and using such extract
AT506041A1 (de) *	2007-12-10	2009-05-15	Univ Innsbruck	Verfahren zur erhöhung der immunreaktivität
US9738680B2 (en)	2008-05-21	2017-08-22	Rheinische Friedrich-Wilhelms-Universität Bonn	5′ triphosphate oligonucleotide with blunt end and uses thereof
EP2343294A1 (en)	2009-11-30	2011-07-13	Bayer Schering Pharma AG	Substituted triazolopyridines
EP2508530A1 (en)	2011-03-28	2012-10-10	Rheinische Friedrich-Wilhelms-Universität Bonn	Purification of triphosphorylated oligonucleotides using capture tags
EP2712870A1 (en)	2012-09-27	2014-04-02	Rheinische Friedrich-Wilhelms-Universität Bonn	Novel RIG-I ligands and methods for producing them
US10344052B2 (en)	2013-03-14	2019-07-09	Health Research, Inc.	Targeting peptides and uses thereof
US11180535B1 (en)	2016-12-07	2021-11-23	David Gordon Bermudes	Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6716575B2 (en) *	1995-12-18	2004-04-06	Sugen, Inc.	Diagnosis and treatment of AUR1 and/or AUR2 related disorders
CA2239692C (en) *	1995-12-18	2008-12-16	Sugen, Inc.	Diagnosis and treatment of aur-1 and/or aur-2 related disorders
US5885803A (en) *	1997-06-19	1999-03-23	Incyte Pharmaceuticals, Inc.	Disease associated protein kinases
WO1999065928A2 (en) *	1998-06-19	1999-12-23	Genzyme Corporation	Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues
WO2001009316A1 (en) *	1999-07-29	2001-02-08	Helix Research Institute	Novel genes encoding protein kinase/protein phosphatase
EP1240194A2 (en) *	1999-11-24	2002-09-18	Sugen, Inc.	Novel human protein kinases and protein kinase-like enzymes
DE60133104T2 (de) *	2000-05-31	2009-03-12	Novartis Vaccines and Diagnostics, Inc., Emeryville	Verfahren und zusammensetzungen zur behandlung von neoplastischen erkrankungen mittels chemotherapie und strahlungssensibilisatoren
US6974667B2 (en) *	2000-06-14	2005-12-13	Gene Logic, Inc.	Gene expression profiles in liver cancer
AU8678501A (en) *	2000-08-24	2002-03-04	Genentech Inc	Compositions and methods for the diagnosis and treatment of tumor
JP2004520806A (ja) *	2000-08-24	2004-07-15	ジェネンテック・インコーポレーテッド	腫瘍の診断と治療のための組成物と方法
KR20040014392A (ko) *	2000-08-24	2004-02-14	제넨테크, 인크.	종양의 진단 및 치료용 조성물 및 방법
CA2427858A1 (en) *	2000-11-03	2002-05-10	University Of Vermont And State Agricultural College	Compositions for inhibiting grb7
US20040029114A1 (en) *	2001-01-24	2004-02-12	Eos Technology, Inc.	Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
EP1418943A1 (en) *	2001-02-14	2004-05-19	Protein Design Labs, Inc.	Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
JP2005527180A (ja) *	2001-04-18	2005-09-15	プロテインデザインラブス，インコーポレイテッド	肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法
WO2002101075A2 (en) *	2001-06-13	2002-12-19	Millennium Pharmaceuticals, Inc.	Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
JP2005508144A (ja) *	2001-06-18	2005-03-31	イオスバイオテクノロジー，インコーポレイティド	卵巣癌の診断方法、卵巣癌のモジュレーターをスクリーニングする組成物及び方法
WO2003042661A2 (en) *	2001-11-13	2003-05-22	Protein Design Labs, Inc.	Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
EP1497454A2 (en) *	2001-11-13	2005-01-19	Protein Design Labs, Inc.	Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
AU2003225535A1 (en) *	2002-01-31	2003-09-02	Millennium Pharmaceuticals, Inc.	Methods and compositions for treating cancer
US20120045390A1 (en) *	2002-09-11	2012-02-23	Genentech, Inc.	Composition and Methods for the Diagnosis and Treatment of Tumor

2003
- 2003-09-05 US US10/526,806 patent/US20120045390A1/en not_active Abandoned
- 2003-09-05 ES ES03752035T patent/ES2359055T3/es not_active Expired - Lifetime
- 2003-09-05 AU AU2003270348A patent/AU2003270348B2/en not_active Expired
- 2003-09-05 CA CA2498000A patent/CA2498000C/en not_active Expired - Lifetime
- 2003-09-05 CA CA2498004A patent/CA2498004C/en not_active Expired - Lifetime
- 2003-09-05 WO PCT/US2003/027894 patent/WO2004024064A2/en not_active Ceased
- 2003-09-05 ES ES03749460.6T patent/ES2456696T3/es not_active Expired - Lifetime
- 2003-09-05 SI SI200331964T patent/SI1546182T1/sl unknown
- 2003-09-05 AU AU2003268494A patent/AU2003268494A1/en not_active Abandoned
- 2003-09-05 JP JP2004536115A patent/JP2005537810A/ja active Pending
- 2003-09-05 EP EP03749460.6A patent/EP1578760B1/en not_active Expired - Lifetime
- 2003-09-05 AT AT03752035T patent/ATE494296T1/de active
- 2003-09-05 JP JP2004536117A patent/JP2006517387A/ja active Pending
- 2003-09-05 EP EP03752035A patent/EP1546182B1/en not_active Expired - Lifetime
- 2003-09-05 DE DE60335636T patent/DE60335636D1/de not_active Expired - Lifetime
- 2003-09-05 WO PCT/US2003/027886 patent/WO2004024063A2/en not_active Ceased
- 2003-09-05 US US10/656,598 patent/US20040229232A1/en not_active Abandoned
2009
- 2009-12-24 JP JP2009293524A patent/JP2010131015A/ja active Pending
2010
- 2010-04-16 AU AU2010201526A patent/AU2010201526A1/en not_active Abandoned
2011
- 2011-08-11 JP JP2011175869A patent/JP2012046515A/ja active Pending
2013
- 2013-03-19 US US13/847,366 patent/US20130210116A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2456696T3 (es)	2014-04-23
JP2010131015A (ja)	2010-06-17
CA2498004C (en)	2013-06-11
CA2498000A1 (en)	2004-03-25
EP1546182B1 (en)	2011-01-05
AU2003270348B2 (en)	2010-08-26
EP1578760B1 (en)	2014-02-12
WO2004024063A3 (en)	2004-10-14
CA2498000C (en)	2015-01-20
ES2359055T3 (es)	2011-05-18
WO2004024064A2 (en)	2004-03-25
ATE494296T1 (de)	2011-01-15
JP2006517387A (ja)	2006-07-27
AU2003268494A1 (en)	2004-04-30
AU2003270348A1 (en)	2004-04-30
EP1546182A2 (en)	2005-06-29
CA2498004A1 (en)	2004-03-25
AU2010201526A1 (en)	2010-05-06
EP1546182A4 (en)	2006-09-06
EP1578760A2 (en)	2005-09-28
US20130210116A1 (en)	2013-08-15
US20120045390A1 (en)	2012-02-23
US20040229232A1 (en)	2004-11-18
JP2005537810A (ja)	2005-12-15
JP2012046515A (ja)	2012-03-08
DE60335636D1 (de)	2011-02-17
EP1578760A4 (en)	2007-07-11
WO2004024063A2 (en)	2004-03-25
WO2004024064A8 (en)	2005-07-21

Publication	Publication Date	Title
MXPA04002593A (es)	2004-05-31	Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es)	2004-03-26	Composiciones y metodos para el diagnostico y tratamiento de tumores.
MXPA05005107A (es)	2005-10-19	Composiciones y metodos para el diagnostico y tratamiento de tumores.
MXPA03001645A (es)	2004-05-14	Composiciones y metodos para el diagnostico y tratamiento de tumores.
ZA200702322B (en)	2009-11-25	Compositions and methods for the diagnosis and treatment of tumor
WO2003088808A3 (en)	2005-10-13	Compositions and methods for the diagnosis and treatment of tumor
SG155947A1 (en)	2009-10-29	Compositions and methods for the diagnosis and treatment of tumor
EP2067472A8 (en)	2010-06-02	Compositions and methods for the diagnosis and treatment of tumor
WO2004112829A3 (en)	2005-03-31	Compositions and methods for the diagnosis and treatment of tumors of glial origin
MXPA05005223A (es)	2010-09-07	Diaminotriazoles utiles como inhibidores de proteinas cinasas.
WO2005049075A3 (en)	2005-11-10	Compositions and methods for the treatment of tumor of hematopoietic origin
MY150531A (en)	2014-01-30	Anti-cd79b antibodies and immunoconjugates and methods of use
WO2002016581A3 (en)	2003-01-16	Compositions and methods for the diagnosis and treatment of tumor
TW200612918A (en)	2006-05-01	Lonidamine analogs
EP1546182A4 (en)	2006-09-06	COMPOSITIONS AND METHOD FOR DIAGNOSING AND TREATING TUMORS
MXPA03001643A (es)	2004-05-14	Composiciones y metodos para el diagnostico y tratamiento de tumores.
WO2005063299A3 (en)	2006-06-01	Compositions and methods for the treatment of tumor of hematopoietic origin
WO2004096124A3 (en)	2004-12-29	Compositions and methods for the diagnosis and treatment of tumor
WO2006110760A3 (en)	2007-03-08	Compositions and methods for the diagnosis and treatment of tumor
EP1590666A4 (en)	2006-07-26	COMPOSITIONS AND METHODS FOR REINFORCED APOPTOSIS
MXPA05008293A (es)	2005-10-18	Composiciones y metodos para el diagnostico y tratamiento de tumores.
MXPA03001644A (es)	2004-05-14	Composiciones y metodos para el diagnostico y tratamiento de tumor.
WO2006014335A3 (en)	2006-07-06	Compositions and methods for treatment of non-hodgkin’s lymphoma
WO2003088898A3 (en)	2004-09-16	Compositions and methods for the diagnosis and treatment of tumor
WO2003090600A3 (en)	2004-08-19	Compositions and methods for the diagnosis and treatment of tumor